VEGF | | | |
| 22 | NS MVD, NS mean survival, NS recurrence | Ellis219 |
| 40 | +MVD, −mean survival, +MVD | Ikeda70 |
| 70 | +MVD, +recurrence, −mean survival | Niedergethmann220 |
| 55 | +MVD, −mean survival | Kuwahara79 |
| 124 | +MVD | Khorana221 |
| 50 | +MVD, −mean survival | Couvelard105 |
FGF | | | |
| 55 | NS MVD, −mean survival | Kuwahara79 |
| 104 | +MVD, +hepatic metastasis, +recurrence | Fujioka222 |
| 20 | +Proliferation index | Yamazaki223 |
PD-ECGF | | | |
(thymidine phosphorylase) | 104 | +MVD, −mean survival, +recurrence, +hepatic metastasis | Fujioka222 |
| 50 | +MVD, −mean survival | Fujimoto69 |
| 40 | −Mean survival | Ikeda70 |
| 55 | NS MVD, NS mean survival | Kuwahara79 |
| 124 | NS MVD | Khorana221 |
HIF | | | |
| 49 | +MVD, +tumour size, +advanced stage, +proliferation index | Kitada224 |
| 55 | +MVD, +metastasis, +VEGF expression, | |
| | −prognosis | Shibaji104 |
| 50 | +MVD | Couvelard105 |